PLCG1_HUMAN - dbPTM
PLCG1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PLCG1_HUMAN
UniProt AC P19174
Protein Name 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
Gene Name PLCG1
Organism Homo sapiens (Human).
Sequence Length 1290
Subcellular Localization Cell projection, lamellipodium. Cell projection, ruffle. Rapidly redistributed to ruffles and lamellipodia structures in response to epidermal growth factor (EGF) treatment.
Protein Description Mediates the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Plays an important role in the regulation of intracellular signaling cascades. Becomes activated in response to ligand-mediated activation of receptor-type tyrosine kinases, such as PDGFRA, PDGFRB, FGFR1, FGFR2, FGFR3 and FGFR4. Plays a role in actin reorganization and cell migration..
Protein Sequence MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQITWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQATSEDEVNMWIKGLTWLMEDTLQAPTPLQIERWLRKQFYSVDRNREDRISAKDLKNMLSQVNYRVPNMRFLRERLTDLEQRSGDITYGQFAQLYRSLMYSAQKTMDLPFLEASTLRAGERPELCRVSLPEFQQFLLDYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVEISADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSMMYSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEVSSSTELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALFDYKAQREDELTFIKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVNPVALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKIMERRKKIALELSELVVYCRPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMTGRHCGYVLQPSTMRDEAFDPFDKSSLRGLEPCAISIEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLELASLLIKIDIFPAKENGDLSPFSGTSLRERGSDASGQLFHGRAREGSFESRYQQPFEDFRISQEHLADHFDSRERRAPRRTRVNGDNRL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAGAASPCA
------CCCCCCCCC
27.8619413330
6Phosphorylation--MAGAASPCANGCG
--CCCCCCCCCCCCC
21.7025159151
18PhosphorylationGCGPGAPSDAEVLHL
CCCCCCCCHHHHHHH
49.2526074081
33PhosphorylationCRSLEVGTVMTLFYS
HHHCCCCCHHEEEEC
16.5723401153
36PhosphorylationLEVGTVMTLFYSKKS
CCCCCHHEEEECCCC
14.9123401153
39PhosphorylationGTVMTLFYSKKSQRP
CCHHEEEECCCCCCC
23.7723401153
40PhosphorylationTVMTLFYSKKSQRPE
CHHEEEECCCCCCCC
26.6923401153
43PhosphorylationTLFYSKKSQRPERKT
EEEECCCCCCCCCEE
34.8523401153
54UbiquitinationERKTFQVKLETRQIT
CCEEEEEEEEEEEEE
29.80-
63O-linked_GlycosylationETRQITWSRGADKIE
EEEEEEECCCHHCCC
16.5229351928
68UbiquitinationTWSRGADKIEGAIDI
EECCCHHCCCCCEEH
41.97-
93PhosphorylationTSRDFDRYQEDPAFR
CCCCHHHHCCCCCCC
20.35-
159UbiquitinationQIERWLRKQFYSVDR
HHHHHHHHHCCCCCC
42.46-
159 (in isoform 2)Ubiquitination-42.46-
162PhosphorylationRWLRKQFYSVDRNRE
HHHHHHCCCCCCCHH
12.8025839225
175UbiquitinationREDRISAKDLKNMLS
HHCCCCHHHHHHHHH
57.72-
175 (in isoform 2)Ubiquitination-57.72-
178UbiquitinationRISAKDLKNMLSQVN
CCCHHHHHHHHHHCC
50.9021906983
178 (in isoform 2)Ubiquitination-50.90-
186PhosphorylationNMLSQVNYRVPNMRF
HHHHHCCCCCCCHHH
17.7122461510
205PhosphorylationLTDLEQRSGDITYGQ
HHHHHHHHCCCCHHH
40.2828787133
209PhosphorylationEQRSGDITYGQFAQL
HHHHCCCCHHHHHHH
26.7528787133
210PhosphorylationQRSGDITYGQFAQLY
HHHCCCCHHHHHHHH
14.84-
219PhosphorylationQFAQLYRSLMYSAQK
HHHHHHHHHHHHHHH
12.16-
226UbiquitinationSLMYSAQKTMDLPFL
HHHHHHHHHCCCCCH
45.6021890473
226 (in isoform 2)Ubiquitination-45.60-
236PhosphorylationDLPFLEASTLRAGER
CCCCHHHHCCCCCCC
20.71-
237PhosphorylationLPFLEASTLRAGERP
CCCHHHHCCCCCCCC
27.58-
304PhosphorylationEFVTFLFSKENSVWN
HHHHHHHCCCCCCHH
41.0024719451
379PhosphorylationPDGMPVIYHGHTLTT
CCCCEEEEECCEEEE
11.28-
389UbiquitinationHTLTTKIKFSDVLHT
CEEEEEEEHHHHHHH
40.1321890473
389UbiquitinationHTLTTKIKFSDVLHT
CEEEEEEEHHHHHHH
40.1321890473
412PhosphorylationSEYPVILSIEDHCSI
CCCCEEEEEEHHCHH
16.89-
428PhosphorylationQQRNMAQYFKKVLGD
HHHHHHHHHHHHHCC
14.0822461510
430UbiquitinationRNMAQYFKKVLGDTL
HHHHHHHHHHHCCCC
36.72-
430 (in isoform 2)Ubiquitination-36.72-
431UbiquitinationNMAQYFKKVLGDTLL
HHHHHHHHHHCCCCC
32.5621890473
431UbiquitinationNMAQYFKKVLGDTLL
HHHHHHHHHHCCCCC
32.5621890473
431 (in isoform 2)Ubiquitination-32.56-
440UbiquitinationLGDTLLTKPVEISAD
HCCCCCCCCEEECCC
47.2221890473
440 (in isoform 2)Ubiquitination-47.22-
451PhosphorylationISADGLPSPNQLKRK
ECCCCCCCHHHHHHH
41.3425159151
456UbiquitinationLPSPNQLKRKILIKH
CCCHHHHHHHHHHCH
41.71-
456 (in isoform 2)Ubiquitination-41.71-
465UbiquitinationKILIKHKKLAEGSAY
HHHHCHHHHCCCCCC
53.28-
465 (in isoform 2)Ubiquitination-53.28-
470PhosphorylationHKKLAEGSAYEEVPT
HHHHCCCCCCCCCCC
21.1221945579
472PhosphorylationKLAEGSAYEEVPTSM
HHCCCCCCCCCCCHH
17.8321945579
477PhosphorylationSAYEEVPTSMMYSEN
CCCCCCCCHHHCCCC
34.1421945579
478PhosphorylationAYEEVPTSMMYSEND
CCCCCCCHHHCCCCH
8.7621945579
481PhosphorylationEVPTSMMYSENDISN
CCCCHHHCCCCHHCH
12.2821945579
482PhosphorylationVPTSMMYSENDISNS
CCCHHHCCCCHHCHH
16.4221945579
487PhosphorylationMYSENDISNSIKNGI
HCCCCHHCHHHHCCE
27.6421945579
489PhosphorylationSENDISNSIKNGILY
CCCHHCHHHHCCEEE
28.3121945579
496PhosphorylationSIKNGILYLEDPVNH
HHHCCEEEEECCCCC
13.2126356563
506PhosphorylationDPVNHEWYPHYFVLT
CCCCCCCCCEEEEEE
4.1626356563
509PhosphorylationNHEWYPHYFVLTSSK
CCCCCCEEEEEECCE
7.2926356563
513PhosphorylationYPHYFVLTSSKIYYS
CCEEEEEECCEEEEE
26.1726356563
514PhosphorylationPHYFVLTSSKIYYSE
CEEEEEECCEEEEEC
26.0226356563
515PhosphorylationHYFVLTSSKIYYSEE
EEEEEECCEEEEECC
20.1726356563
518PhosphorylationVLTSSKIYYSEETSS
EEECCEEEEECCCCC
12.5028450419
519PhosphorylationLTSSKIYYSEETSSD
EECCEEEEECCCCCC
17.0628450419
520PhosphorylationTSSKIYYSEETSSDQ
ECCEEEEECCCCCCC
16.4028450419
523PhosphorylationKIYYSEETSSDQGNE
EEEEECCCCCCCCCC
29.4925159151
524PhosphorylationIYYSEETSSDQGNED
EEEECCCCCCCCCCC
34.8925159151
525PhosphorylationYYSEETSSDQGNEDE
EEECCCCCCCCCCCC
41.1823927012
539PhosphorylationEEEPKEVSSSTELHS
CCCCCCCCCCCCCCC
21.4725159151
540PhosphorylationEEPKEVSSSTELHSN
CCCCCCCCCCCCCCC
46.5923186163
541PhosphorylationEPKEVSSSTELHSNE
CCCCCCCCCCCCCCC
20.5623186163
542PhosphorylationPKEVSSSTELHSNEK
CCCCCCCCCCCCCCC
44.5123927012
546PhosphorylationSSSTELHSNEKWFHG
CCCCCCCCCCCCCCC
60.3523186163
549UbiquitinationTELHSNEKWFHGKLG
CCCCCCCCCCCCCCC
60.45-
554UbiquitinationNEKWFHGKLGAGRDG
CCCCCCCCCCCCCCH
34.87-
554 (in isoform 2)Ubiquitination-34.87-
582PhosphorylationETGAPDGSFLVRESE
HHCCCCCCEEEEECC
23.8428857561
666UbiquitinationQTNAHESKEWYHASL
CCCCCCCHHHHHHHC
49.64-
666 (in isoform 2)Ubiquitination-49.64-
669PhosphorylationAHESKEWYHASLTRA
CCCCHHHHHHHCHHH
6.65-
701PhosphorylationRKRNEPNSYAISFRA
EECCCCCCEEEEEEE
27.0228152594
702PhosphorylationKRNEPNSYAISFRAE
ECCCCCCEEEEEEEE
18.0028152594
705PhosphorylationEPNSYAISFRAEGKI
CCCCEEEEEEEECCC
10.6628152594
763UbiquitinationINEEALEKIGTAEPD
CCHHHHHHHCCCCCC
47.49-
763 (in isoform 2)Ubiquitination-47.49-
766PhosphorylationEALEKIGTAEPDYGA
HHHHHHCCCCCCCCC
31.1821945579
771PhosphorylationIGTAEPDYGALYEGR
HCCCCCCCCCCCCCC
18.2721945579
775PhosphorylationEPDYGALYEGRNPGF
CCCCCCCCCCCCCCC
18.7921945579
783PhosphorylationEGRNPGFYVEANPMP
CCCCCCCEEECCCCC
11.8625159151
791PhosphorylationVEANPMPTFKCAVKA
EECCCCCCHHHHHHH
29.4921945579
793UbiquitinationANPMPTFKCAVKALF
CCCCCCHHHHHHHHH
24.62-
793 (in isoform 2)Ubiquitination-24.62-
797UbiquitinationPTFKCAVKALFDYKA
CCHHHHHHHHHCHHC
22.35-
797 (in isoform 2)Ubiquitination-22.35-
803UbiquitinationVKALFDYKAQREDEL
HHHHHCHHCCCCCHH
39.63-
815PhosphorylationDELTFIKSAIIQNVE
CHHHHHHHHHHCCEE
21.6427251275
823UbiquitinationAIIQNVEKQEGGWWR
HHHCCEEECCCCCCC
49.74-
833PhosphorylationGGWWRGDYGGKKQLW
CCCCCCCCCCCEEEE
30.5125839225
890UbiquitinationIAIRPEGKNNRLFVF
EEECCCCCCCEEEEE
49.76-
890 (in isoform 2)Ubiquitination-49.76-
932PhosphorylationKIREVAQTADARLTE
HHHHHHHHHHHHCCC
19.4328509920
941UbiquitinationDARLTEGKIMERRKK
HHHCCCCHHHHHHHH
32.4221890473
941AcetylationDARLTEGKIMERRKK
HHHCCCCHHHHHHHH
32.4225953088
941UbiquitinationDARLTEGKIMERRKK
HHHCCCCHHHHHHHH
32.4221890473
941 (in isoform 2)Ubiquitination-32.42-
954PhosphorylationKKIALELSELVVYCR
HHHHHHHHHHEEEEE
21.36-
959PhosphorylationELSELVVYCRPVPFD
HHHHHEEEEECCCCC
3.85-
972PhosphorylationFDEEKIGTERACYRD
CCHHHHCCCCHHCCC
26.2724719451
977PhosphorylationIGTERACYRDMSSFP
HCCCCHHCCCHHHCC
14.5225159151
981PhosphorylationRACYRDMSSFPETKA
CHHCCCHHHCCHHHH
32.8730576142
982PhosphorylationACYRDMSSFPETKAE
HHCCCHHHCCHHHHH
37.8830576142
987AcetylationMSSFPETKAEKYVNK
HHHCCHHHHHHHHHH
53.5425953088
987UbiquitinationMSSFPETKAEKYVNK
HHHCCHHHHHHHHHH
53.54-
987 (in isoform 2)Ubiquitination-53.54-
990AcetylationFPETKAEKYVNKAKG
CCHHHHHHHHHHHHC
60.4025953088
991PhosphorylationPETKAEKYVNKAKGK
CHHHHHHHHHHHHCC
10.76-
999AcetylationVNKAKGKKFLQYNRL
HHHHHCCHHHHHCCE
61.0325953088
1003PhosphorylationKGKKFLQYNRLQLSR
HCCHHHHHCCEEHHC
12.3729496907
1079UbiquitinationEAFDPFDKSSLRGLE
CCCCCCCHHHCCCCC
42.18-
1079 (in isoform 2)Ubiquitination-42.18-
1128PhosphorylationYDSTKQKTEFVVDNG
CCCCCCEEEEEECCC
31.9622468782
1150PhosphorylationKPFHFQISNPEFAFL
CCEEEEECCCCEEEE
35.2322468782
1162PhosphorylationAFLRFVVYEEDMFSD
EEEEEEEEEHHHCCC
14.32-
1193UbiquitinationGYRAVPLKNNYSEDL
CEEEEECCCCCCCCH
36.76-
1193 (in isoform 2)Ubiquitination-36.76-
1196PhosphorylationAVPLKNNYSEDLELA
EEECCCCCCCCHHHH
23.8829496907
1215 (in isoform 2)Ubiquitination-52.53-
1221PhosphorylationAKENGDLSPFSGTSL
CCCCCCCCCCCCCCH
28.7419664994
1222 (in isoform 2)Phosphorylation-34.4230266825
1224PhosphorylationNGDLSPFSGTSLRER
CCCCCCCCCCCHHHC
44.5430266825
1225 (in isoform 2)Phosphorylation-21.5027987026
1226PhosphorylationDLSPFSGTSLRERGS
CCCCCCCCCHHHCCC
24.3230266825
1227PhosphorylationLSPFSGTSLRERGSD
CCCCCCCCHHHCCCC
29.0230266825
1227 (in isoform 2)Phosphorylation-29.0227987026
1228 (in isoform 2)Phosphorylation-7.0922199227
1231MethylationSGTSLRERGSDASGQ
CCCCHHHCCCCCCCC
43.40115487745
1233PhosphorylationTSLRERGSDASGQLF
CCHHHCCCCCCCCCC
35.9025159151
1236PhosphorylationRERGSDASGQLFHGR
HHCCCCCCCCCCCCC
31.8723927012
1243MethylationSGQLFHGRAREGSFE
CCCCCCCCCCCCCCH
23.15115487755
1248PhosphorylationHGRAREGSFESRYQQ
CCCCCCCCCHHHCCC
22.5323401153
1251PhosphorylationAREGSFESRYQQPFE
CCCCCCHHHCCCCHH
33.9929255136
1253PhosphorylationEGSFESRYQQPFEDF
CCCCHHHCCCCHHHC
22.3023927012
1263PhosphorylationPFEDFRISQEHLADH
CHHHCCCCHHHHHHH
25.8423401153
1273PhosphorylationHLADHFDSRERRAPR
HHHHHCCCCCCCCCC
34.7929255136
1283MethylationRRAPRRTRVNGDNRL
CCCCCCCCCCCCCCC
20.35115487765

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
771YPhosphorylationKinaseABL1P00519
GPS
771YPhosphorylationKinaseEGFRP00533
PSP
771YPhosphorylationKinaseSYKQ15046
PhosphoELM
771YPhosphorylationKinaseLCKP06239
GPS
771YPhosphorylationKinaseSYKP43405
Uniprot
783YPhosphorylationKinaseSYKP43405
Uniprot
783YPhosphorylationKinaseTXKP42681
Uniprot
783YPhosphorylationKinaseSYKQ15046
PhosphoELM
783YPhosphorylationKinaseRETP07949
PSP
783YPhosphorylationKinasePDGFRBP09619
PSP
783YPhosphorylationKinaseLCKP06239
GPS
783YPhosphorylationKinaseITKQ08881
Uniprot
783YPhosphorylationKinaseEGFRP00533
PSP
1003YPhosphorylationKinaseABL1P00519
GPS
1248SPhosphorylationKinasePRKCAP17252
GPS
1248SPhosphorylationKinasePRKACAP17612
GPS
1248SPhosphorylationKinaseAKT1P31749
PSP
1248SPhosphorylationKinasePKA-FAMILY-GPS
1248SPhosphorylationKinasePKA_GROUP-PhosphoELM
1253YPhosphorylationKinaseEGFRP00533
PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseCBLBQ13191
PMID:15308098
-KUbiquitinationE3 ubiquitin ligaseCBLP22681
PMID:16467851
-KUbiquitinationE3 ubiquitin ligaseITCHQ96J02
PMID:22199232
-KUbiquitinationE3 ubiquitin ligasePRKNO60260
PMID:18671761

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PLCG1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PLCG1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EF1A1_HUMANEEF1A1physical
11886851
GIT1_HUMANGIT1physical
14523024
LYAM2_HUMANSELEphysical
12960351
PLD2_HUMANPLD2physical
12646582
SRC_HUMANSRCphysical
7510703
WASP_HUMANWASphysical
8805332
VAV_HUMANVAV1physical
9891995
KHDR1_HUMANKHDRBS1physical
11960376
GAB1_HUMANGAB1physical
11507676
LCP2_HUMANLCP2physical
11390650
GRB2_HUMANGRB2physical
9281317
KHDR1_HUMANKHDRBS1physical
9743338
RASA1_HUMANRASA1physical
9743338
3BP2_HUMANSH3BP2physical
11390470
KSYK_HUMANSYKphysical
7831290
LAT_HUMANLATphysical
9729044
RHOA_HUMANRHOAphysical
12071848
PKN2_HUMANPKN2physical
8910519
ALK_HUMANALKphysical
11888936
PAK1_HUMANPAK1physical
12085993
FAK1_HUMANPTK2physical
10430888
KPCD1_HUMANPRKD1physical
8885868
HNRPQ_HUMANSYNCRIPphysical
9341187
PGFRA_HUMANPDGFRAphysical
7535778
NTRK1_HUMANNTRK1physical
10092678
NTRK2_HUMANNTRK2physical
10092678
NTRK3_HUMANNTRK3physical
10092678
RET_HUMANRETphysical
8628282
TNK1_HUMANTNK1physical
10873601
KIT_HUMANKITphysical
7536744
ERBB2_HUMANERBB2physical
1676673
ERBB2_HUMANERBB2physical
1683701
WASP_HUMANWASphysical
8824280
CBL_HUMANCBLphysical
12061819
CBL_HUMANCBLphysical
9712732
IRS2_HUMANIRS2physical
9535722
SOS1_HUMANSOS1physical
10913276
GHR_HUMANGHRphysical
9632636
SOS2_HUMANSOS2physical
10940929
TUB_HUMANTUBphysical
10455176
EGFR_HUMANEGFRphysical
9207933
GAB2_HUMANGAB2physical
10391903
GELS_HUMANGSNphysical
9164868
PLXB1_HUMANPLXNB1physical
19805522
PLXB2_HUMANPLXNB2physical
19805522
CBL_HUMANCBLphysical
12941616
BLNK_HUMANBLNKphysical
10684856
CBL_HUMANCBLphysical
12803489
EGFR_HUMANEGFRphysical
12803489
EF1A1_HUMANEEF1A1physical
12898421
IBTK_HUMANIBTKphysical
18596081
SPY1_HUMANSPRY1physical
19915061
CBL_HUMANCBLphysical
16467851
VAV_HUMANVAV1physical
16467851
LCP2_HUMANLCP2physical
16467851
ZAP70_HUMANZAP70physical
16467851
LAT_HUMANLATphysical
16467851
ERBB3_HUMANERBB3physical
16273093
KHDR1_HUMANKHDRBS1physical
8977179
RASA1_HUMANRASA1physical
8977179
EHD4_HUMANEHD4physical
22863883
TF3C4_HUMANGTF3C4physical
22863883
LIMD1_HUMANLIMD1physical
22863883
PYGB_HUMANPYGBphysical
22863883
AKT1_HUMANAKT1physical
16525023
PYRG1_HUMANCTPS1physical
26344197
MCMBP_HUMANMCMBPphysical
26344197
PEPL1_HUMANNPEPL1physical
26344197
SKIV2_HUMANSKIV2Lphysical
26344197
TIPRL_HUMANTIPRLphysical
26344197
UN45A_HUMANUNC45Aphysical
26344197
EGFR_HUMANEGFRphysical
11983899
PTN6_HUMANPTPN6physical
27221712
EGFR_HUMANEGFRphysical
19605547
FGFR2_HUMANFGFR2physical
15629145
GRB2_HUMANGRB2physical
16038803

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PLCG1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6 AND SER-525, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-775; TYR-783;SER-1221; TYR-1253 AND SER-1263, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6 AND SER-525, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1221, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1263, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-775 ANDTYR-783, AND MASS SPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-783 ANDTYR-1253, AND MASS SPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-977, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771 AND TYR-1253, ANDMASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771 AND TYR-775, ANDMASS SPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-775 AND TYR-783, ANDMASS SPECTROMETRY.
"Vascular endothelial growth factor (VEGF)-D and VEGF-A differentiallyregulate KDR-mediated signaling and biological function in vascularendothelial cells.";
Jia H., Bagherzadeh A., Bicknell R., Duchen M.R., Liu D., Zachary I.;
J. Biol. Chem. 279:36148-36157(2004).
Cited for: PHOSPHORYLATION AT TYR-783 IN RESPONSE TO KDR ACTIVATION.
"Membrane raft-dependent regulation of phospholipase Cgamma-1activation in T lymphocytes.";
Veri M.C., DeBell K.E., Seminario M.C., DiBaldassarre A., Reischl I.,Rawat R., Graham L., Noviello C., Rellahan B.L., Miscia S.,Wange R.L., Bonvini E.;
Mol. Cell. Biol. 21:6939-6950(2001).
Cited for: PHOSPHORYLATION AT TYR-783, AND SUBCELLULAR LOCATION.
"Phospholipase C-gamma1 interacts with conserved phosphotyrosylresidues in the linker region of Syk and is a substrate for Syk.";
Law C.L., Chandran K.A., Sidorenko S.P., Clark E.A.;
Mol. Cell. Biol. 16:1305-1315(1996).
Cited for: PHOSPHORYLATION AT TYR-771 AND TYR-783 BY SYK, AND INTERACTION WITHSYK.

TOP